TLR2 modulates inflammation in zymosan-induced arthritis in mice

The interplay between the innate and acquired immune systems in chronic inflammation is not well documented. We have investigated the mechanisms of inflammation in murine zymosan-induced arthritis (ZIA) in the light of recent data on the roles of Toll-like receptor 2 (TLR2) and Dectin-1 in the activation of monocyte/macrophages by zymosan. The severity of inflammation, joint histology, lymphocyte proliferation and antibody production in response to zymosan were analyzed in mice deficient in TLR2 and complement C3, and the effects of Dectin-1 inhibition by laminarin were studied. In comparison with wild-type animals, TLR2-deficient mice showed a significant decrease in the early (day 1) and late phases (day 24) of joint inflammation. C3-deficient mice showed no differences in technetium uptake or histological scoring. TLR2-deficient mice also showed a significant decrease in lymph node cell proliferation in response to zymosan and a lower IgG antibody response to zymosan at day 25 in comparison with wild-type controls, indicating that TLR2 signalling has a role in the development of acquired immune responses to zymosan. Although laminarin, a soluble β-glucan, was able to significantly inhibit zymosan uptake by macrophages in vitro, it had no effect on ZIA in vivo. These results show that ZIA is more prolonged than was originally described and involves both the innate and acquired immune pathways. C3 does not seem to have a major role in this model of joint inflammation.

[1]  Siamon Gordon,et al.  The Role of SIGNR1 and the β-Glucan Receptor (Dectin-1) in the Nonopsonic Recognition of Yeast by Specific Macrophages1 , 2004, The Journal of Immunology.

[2]  D. Fearon,et al.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Gordon,et al.  PTX3 function as an opsonin for the dectin‐1‐dependent internalization of zymosan by macrophages , 2004, Journal of leukocyte biology.

[4]  T. T. Stevenson,et al.  A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1–3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes* , 1998, The Journal of Biological Chemistry.

[5]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[6]  Siamon Gordon,et al.  Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.

[7]  J. V. Fiore,et al.  On the composition of zymosan. , 1958, Science.

[8]  L. Putte,et al.  Detection and quantification of experimental joint inflammation in mice by measurement of99mTc-pertechnetate uptake , 1981, Agents and Actions.

[9]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[10]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[11]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[12]  A C Allison,et al.  Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. , 1977, Arthritis and rheumatism.

[13]  E. Keystone,et al.  Zymosan—Induced Arthritis , 1977 .

[14]  J. Kalbfleisch,et al.  Human monocyte scavenger receptors are pattern recognition receptors for (1→3)‐β‐D‐glucans , 2002, Journal of leukocyte biology.

[15]  W. B. van den Berg,et al.  Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis. , 1999, Cytokine.

[16]  S. Gordon,et al.  The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages1 , 2002, The Journal of Immunology.

[17]  R. Gay,et al.  Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. , 2003, The American journal of pathology.

[18]  D. Bitter‐Suermann,et al.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. , 1977, Immunology.

[19]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Adrian Ozinsky,et al.  Phagocytosis of microbes: complexity in action. , 2002, Annual review of immunology.

[21]  P. Butko,et al.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Gordon,et al.  Immune recognition: A new receptor for β-glucans , 2001, Nature.

[23]  Pj Delves,et al.  Slide Atlas of Essential Immunology. 4 volumes, 521 slides. Blackwell Scientific Publications. Oxford, UK , 1992 .

[24]  P. Godowski,et al.  Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[25]  D. Underhill.  Macrophage recognition of zymosan particles , 2003, Journal of endotoxin research.

[26]  P. Lachmann,et al.  Specificity of membrane complement receptor type three (CR3) for beta-glucans. , 1987, Complement.

[27]  L. Jones,et al.  TLR2 is expressed on activated T cells as a costimulatory receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[29]  David L. Williams,et al.  Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. , 1996, Journal of immunology.

[30]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[31]  R. Ritter,et al.  Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning* , 2000, The Journal of Biological Chemistry.

[32]  L. Joosten,et al.  Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. , 1995, Arthritis and rheumatism.

[33]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[34]  Hazel M. Dockrell.  Roitt's essential immunology, 10th edition. I. M. Roitt & P. J. Delves. Oxford: Blackwell Science, 2001. xi+481pp. Price £24.95. ISBN 0-632-05902-8 , 2002 .

[35]  S. J. Riggi,et al.  The effects of laminarin, sulfated glucan and oligosaccharides of glucan on reticuloendothelial activity. , 1970, Journal of the Reticuloendothelial Society.

[36]  P. Ricciardi-Castagnoli,et al.  Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming1 , 2003, The Journal of Immunology.

[37]  E. Bernotiene,et al.  Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice , 2004, Arthritis research & therapy.